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Abstract
Thymic microenvironments are essential for the proper development and selection of T cells critical for a functional
and self-tolerant adaptive immune response. While significant turnover occurs, it is unclear whether populations of
adult stem cells contribute to the maintenance of postnatal thymic epithelial microenvironments. Here, the slow
cycling characteristic of stem cells and their property of label-retention were used to identify a K5-expressing thymic
stromal cell population capable of generating clonal cell lines that retain the capacity to differentiate into a number of
mesenchymal lineages including adipocytes, chondrocytes and osteoblasts suggesting a mesenchymal stem cell-like
phenotype. Using cell surface analysis both culture expanded LRCs and clonal thymic mesenchymal cell lines were
found to express Sca1, PDGFRα, PDGFRβ,CD29, CD44, CD49F, and CD90 similar to MSCs. Sorted GFP-
expressing stroma, that give rise to TMSC lines, contribute to thymic architecture when reaggregated with fetal
stroma and transplanted under the kidney capsule of nude mice. Together these results show that the postnatal
thymus contains a population of mesenchymal stem cells that can be maintained in culture and suggests they may
contribute to the maintenance of functional thymic microenvironments.
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Introduction
The thymus is responsible for the generation of new T cells
from hematopoietic stem cells (HSC) and the selection of T
cells expressing a functional self-tolerant T cell receptor (TCR).
Unique thymic epithelial microenvironments in the thymic
stroma control these critical processes [1]. The thymic stroma
is broadly divided into two distinct regions called the cortex and
the medulla. Cortical TECs (cTECs) are responsible for the
attraction of T cell precursors, commitment to the T cell
lineage, expansion of immature double-negative (DN)
thymocytes and positive selection of double positive (DP)
thymocytes [2]. Medullary thymic epithelial cells (mTECs) are a
heterogeneous population of cells that create a
microenvironment necessary for the maturation of CD4 and
CD8 single positive (SP) thymocytes. mTECs express a wide
array of tissue restricted antigens (TRAs) [3-5] that, when
presented in the context of major histocompatibility complex
class II (MHCII)+ on mTECs and dendritic cells, function to
negatively select thymocytes that bear high affinity self-reactive
TCRs [6]. In addition to TECs, mesenchymal cells have also
been shown to be important for the initial development and
subsequent maintenance of a functional thymic
microenvironment [7,8].
In adulthood, thymic atrophy results in a progressive loss of
normal thymic cortical and medullary epithelial architecture and
a subsequent reduced capacity to generate mature T cells.
This atrophy involves a transition to a thymus enriched in
fibroblasts and ultimately adipocytes, which appear to arise
through epithelial mesenchyme transition [9-11]. Interestingly,
thymic atrophy appears to be reversible, allowing normal
thymic architecture and T cell output to be restored [12]. These
studies show a plasticity of the thymic architecture and suggest
that TEC progenitors persist in the adult thymus and can be
activated to proliferate and differentiate later in life.
Stem cells (SCs) are unique in their ability to self-renew and
to differentiate into the cell lineages that make up their tissue of
origin. Stem cells with the capacity to regenerate their specific
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tissue of origin have been identified in numerous adult tissues,
including the bone marrow, epidermis, hair follicle, intestine,
brain, testis and cornea [13-15]. Another class of multipotent or
potentially pluripotent cells, the mesenchymal stem cells
(MSCs) are resident in virtually all postnatal tissues and organs
[16-19].
Due to their minority status in adult tissues and a limited
number of defining cell surface markers, identification of adult
stem cells has relied primarily on anatomical characteristics
and their slow cycling properties. Recently, however, Tumbar
et al [20] utilized a novel H2BGFP transgenic system to mark
infrequently cycling cells of adult skin epithelium. These label-
retaining cells (LRCs) were shown to be stem cells. In this
study we used this transgenic model to identify a population of
LRCs in the postnatal thymus. These LRCs, and clonal lines
derived from sorted thymic stroma with the same surface
characteristics, exhibited enhanced in vitro growth potential
and, when subjected to different culture conditions, were found
to have retained the capacity to differentiate into adipocytes,
chondrocytes and osteocytes. This multipotentiality is highly
reminiscent of mesenchymal stem cells. When sorted
populations of these cells were reaggregated with fetal stroma
and transferred under the kidney capsule they contributed to
the resulting thymus as TECs. Therefore, our studies
demonstrate previously unrecognized developmental plasticity
for EpCAM–expressing cells in the postnatal thymus and
suggest that TMSCs may contribute to maintenance of




All mice used in this study were bred and maintained at the
City College of New York animal facility and all experiments
were performed with approval from the City College of New
York Institutional Animal Care and Use Committee. The animal
care facility at the City College of New York is certified at both
the State and Federal levels. The CCNY animal assurance
number is A3733-01.
Mice
Dr. Adam Glick (Penn State University) generously provided
K5tTA mice. TetO-H2BGFP mice have been previously
described [21-24]. TetO-H2BGFP, Nude, and C57BL/6JJ mice
were obtained from the Jackson Laboratory (Bar Harbor, ME).
Adult TetO-H2BGFP;K5tTA DT and litter mate heterozygous
control animals were fed mouse diet containing doxycycline
(Dox) (2 g/kg, BioServe, NJ) for 8 weeks to 6 months beginning
at 4 weeks of age, unless otherwise indicated.
Antibodies
The following primary antibodies were used for experiments:
CD45-PE Cy7, CD45-APC Cy7 (clone 30-F11, BD Bioscience),
I-A/I-E-APC (clone M5/114.15.2, BD Bioscience), cytokeratin 5
(MK-5, Covance), cytokeratin 14 (MK-14, Covance), Troma I
(Developmental Studies Hybridoma Bank, IA), MTS10 (kindly
provided by Dr. Richard Boyd from Monash University,
Australia), ΔNP63 (clone N-16, Santa Cruz), Aire (clone M-300,
Santa Cruz), EpCAM-PE (clone G8.8, eBioscience), Ki67-FITC
(clone B56, BD Bioscience), Ki67 (clone SP6, LabVision),
Sca1-PE Cy7, Sca1-APC Cy7(clone D7, eBioscience), CD49F-
Biotin (eBioGoH3, eBioscience), CD29-FITC, CD29-PE
Cy7(clone Ha2/5, eBioscience) , Laminin (Millipore). CD106-
FITC (BD Bioscience), CD140a-Biotin(clone APA5,
eBioscience), CD140b-PE (clone APB5, eBioscience), CD44-
APC (clone IM7, BD Bioscience), CD90.2(clone 30-H12, BD
Bioscience), CD34-PE (clone RAM#4, eBioscience),
SSEA1(clone MC480, Stem Cell Tecnologies), Rabbit anti-GFP
(Life), CD80 (eBioscience), and CD205 (LY75/DEC-205) clone
HD30 (Millipore), Rat IgG2a isotype-PE, Rat IgG2a isotype-
FITC, Rat IgG2a isotype-PE-Cy7, Rat IgG2a isotype-PerCP
Cy5.5, Rat IgG2a isotype-APC Cy7, Rat IgG2a isotype-APC
and Rat IgG2a isotype-Biotin (BD Bioscience). The following
secondary reagents were used for experiments: donkey anti
rabbit IgG-TRITC, donkey anti rabbit IgG-Cy5, donkey anti
rabbit IgG-FITC, donkey anti rat IgG-TRITC, donkey anti goat
IgG-FITC, goat anti rat IgM-TRITC (Jackson
ImmunoResearch), anti-rat IgG2a-FITC, anti-rat IgM-FITC,
stretavidin-APC, stretavidin-APC Cy7, streptavidin-PerCP
Cy5.5 (BD Bioscience) and stretavidin-TRITC (Southern
Biotechnology Associate).
Thymic stromal cell preparation
Embryonic thymi were digested with Dispase (1 mg/mL) and
Deoxyribonuclease I solution (1 μg/mL), (Stem Cell
Technologies) at 37°C for 15 minutes with occasional gentle
agitation with a glass Pasteur pipette. The resulting single cell
suspension was washed with PBS and passed through 100μm
strainer (BD Bioscience) to remove any remaining undigested
tissue. Adult thymi were cut into small pieces and the majority
of thymocytes were released by gentle agitation using a glass
Pasteur pipette. The resulting tissue fragments were digested
with Collagenase/Hyaluronidase in Dulbecco’s Modified
Eagle’s Medium (Stem Cell Technologies) for 15 minutes at
37°C followed by Dispase (1 mg/mL) and Deoxyribonuclease I
solution (0.1 μg/mL), (Stem Cell Technologies) for 5 minutes at
37°C. The single cell suspension was washed with PBS and
passed through a 100μm strainer (BD Bioscience).
Flow cytometery
Cells were suspended in 100 μl of FACS staining buffer
(FSB-1% fetal bovine serum, 5 mM EDTA and 0.02% NaN3 in
PBS) with appropriately diluted primary antibodies for 20
minutes on ice in the dark. Secondary antibodies appropriately
diluted in FSB were added cells were incubated for an
additional 20 minutes on ice in the dark. After washing, cells
were resuspended in 500 μl of FSB for data acquisition. Live/
dead discrimination was applied using ToPro3 (Invitrogen).
Data acquisition was performed using an LSRII analyzer
complete with three lasers (BD Bioscience) and cell sorting
was performed using a FACS Aria (BD Bioscience). FACS data
was analyzed using Flow Jo software (Tree Star) or FACS Diva
software (BD Bioscience).
Thymic Mesenchymal Stem Cells
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Immunohistochemistry and confocal microscopy
Fresh tissues were embedded in OCT medium (Fisher);
snap frozen and sectioned (8μm) using a Leica CM1950
Cryostat. Sections were air dried on bond-rite slides and then
fixed in 4% paraformaldehyde followed by 100% ice-cold
acetone. Sections were washed with PBS and blocked with
blocking buffer (1% BSA, 0.1%Triton-X, 5% normal serum in
PBS) for 10 min. Sections were incubated with appropriately
diluted primary antibodies in blocking buffer in a humidified
chamber for 1 hour at 37°C followed by incubation with
secondary reagents diluted in blocking buffer in humidified
chamber for 30 minutes at 37°C, then mounted with ProLong
gold anti-fade reagent with DAPI (Invitrogen). Isotype control
staining was performed for all primary antibodies to ensure
specificity of staining. Images were acquired using Zeiss
LSM510 confocal microscope and analyzed using LSM
software (Zeiss).
RNA isolation and gene expression analysis
Total RNA was isolated from sorted EpCAM+ thymic
epithelial cells or cultured cells using Trizol reagent
(Invitrogen). RT-PCR was performed using SuperScript III first-
strand synthesis system (Invitrogen). End point PCR gene
expression analysis of sorted TECs and TMSC clonal lines was
performed using a BioRad MyCycler. The cycling condition was
95°C for 2 minutes for the initial denature followed by 95°C 30
seconds, 55°C 30 seconds and 72°C 45 seconds for 40 cycles
with the final extension of 5 minutes at 72°C. The amplified
PCR products were visualized on 2% agrose gel containing
0.5μg/mL ethidium bromide and images were captured using a
Kodak Gel Logic 100 for documentation. The primers used for



















Eya1 F- GGTGTGGAAGAAGAGCAAGGG, R-
TGACACAAGAAGACAAGCCTGC[25]
FoxN1 F- ACTGACCTGGATGCTATCAACCC, R-
TGTTTCTGCCAGACAAGGCC[25]




Quantitative PCR of TMSCs and sorted TECs
RNA was denatured in the presence of Random hexamers
(Applied Biosystems N808-0127) and dNTPs at 65OC for 5
minutes. The denatured RNA was then used to synthesize
cDNA using 5X buffer (Invitrogen y02321), DTT (Invitrogen
y00147), SuperScriptIII (Invitrogen 18080-044), and RNase
inhibitor (Invitrogen 1077-019) at 25OC for 10 minutes followed
by 50OC for 50 minutes and 85OC for 5 minutes. The
synthesized cDNA was subsequently used to preform
quantitative real-time PCR using TaqMan universal master mix
(Applied Biosystems 4369016) using the following TaqMan
assay probes obtained from Applied Biosciences: 18srRNA
(#4333760), Foxn1 (Mm00433946 m1) EpCAM
(Mm00493214m1) Nanog (Mm02019550 s1), Oct4
(Mm03053917 g1), Sox2 (Mm00488369 s1). Applied
Biosystems instrument default cycling protocol was used to
perform q-RT-PCR using a 7500 RT-PCR system.
TMSC Cell culture and clonal cell line development
Thymic stromal cells were harvested and sorted based on
the surface markers. Sorted cells were plated on 96 well plates
coated with Laminin/Entactin (50μg/mL) in thymic stromal
culture medium, MEM alpha containing 10% fetal bovine
serum, penicillin-streptomycin, gentamycin supplemented with
recombinant human LIF (10ng/mL), recombinant mouse EGF
(50 ng/mL) and recombinant bFGF (20 ng/mL) (Invitrogen) until
near confluence. Cells were gradually expanded into 24 well
plates, 6 well plates and 100mm plates. Following expansion,
cells were cloned by limiting dilution. Cells were passaged
every 7 days.
Differentiation Assays
For adipogenic differentiation, 3 x 104 thymic stromal cells or
clonal TMSC cell lines were plated/ well of 6 well plates
containing keratinocyte serum free medium (Invitrogen)
supplemented with 10% fetal bovine serum, 0.18 mM calcium
chloride, penicillin-streptomycin, gentamycin and recombinant
mouse EGF (10 ng/mL), in the presence or absence of 5μM
PPARγ inhibitor PW9662 (Sigma Aldrich), for 2 weeks with the
medium changed every 3-4 days.
For osteogenic differentiation, 3 x 104 thymic stromal cells or
cell lines were plated/well in 6 well plates containing Human/
Mouse StemXVivo Osteogenic/Adipogenic Base Media
supplemented with Mouse StemXVivo Osteogenic Supplement
(R&D systems) for 2 weeks, with medium changes every 3-4
days.
For chondrogenic differentiation, 3 x 104 thymic stromal cells
or clonal cell lines were maintained as a pellet after gentle
centrifugation in 15 mL Falcon tubes containing Human/Mouse
StemXVivo Chondrogenic Base Media supplemented with
Human/Mouse StemXVivo Chondrogenic Supplement (R&D
systems) for 3 weeks with medium changes every 3-4 days.
Confirmation of adipogenic, osteogenic and chondrogenic
differentiation were performed by Oil red O staining, Alkaline
phosphatase and Alizarin Red S staining, and Alcian blue
staining, respectively.
Thymic Mesenchymal Stem Cells
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Mixed thymic reaggregates and kidney capsule
transplants
Fetal thymic tissue was harvested from E15.5 fetal C57BL/6J
mice. Tissue was cleaned to remove excess blood and
adhering non-thymic tissue and then lobes were torn using
forceps and washed repeatedly using a Pasteur pipette in 1 x
PBS pH 7.4 to remove excess thymocytes. Embryonic thymi
were digested with Dispase (1 mg/mL) and Deoxyribonuclease
I solution (1 μg/mL), (Stem Cell Technologies) at 37°C for 15
minutes with occasional gentle agitation with a glass Pasteur
pipette. The resulting single cell suspension was washed with
PBS and passed through 100μm strainer (BD Bioscience) to
remove any remaining undigested tissue. Adult thymus was
dissociated from C57BL/6J eGFP-expressing mice (Jax), as
described above, and subsets of adult stromal cells were
sorted to greater than 95% purity on a BD FACS ARIAII sorter.
2-5 x105 dissociated fetal stroma were mixed with 1-2 x 104
FACS purified adult eGFP-expressing stroma and centrifuged
at 1000G on a microfuge. Residual media was aspirated and
the cell pellets were vortexed briefly. The resulting slurry was
transferred to the surface of a 0.8μm polycarbonate filter
(Millipore) supported on a transwell plate above RPMI FTOC
medium and cultured for 48hrs at 37°C in 5% CO2. The
resulting reaggregates were photographed to confirm the
presence of eGFP-expressing adult cells and then surgically
transferred under the kidney capsule of nude mice and allowed
to grow for 3 weeks prior to harvest and preparation of cryostat
sections.
Results
Localization and Characterization of H2BGFP label-
retaining cells in the postnatal thymus
The K5tTA;TetO-H2BGFP double transgenic model,
developed by Tumbar et al. [20] was used to identify label-
retaining epithelial stem cells in the thymus. Briefly, mice
expressing the tetracycline controlled transactivator as well as
the Herpes Simplex Viral protein, VP16, driven by the Keratin 5
(K5) promoter (K5tTA) were bred to mice containing a
transgene consisting of the tetracycline response element
(TRE) ahead of a CMV promoter controlling expression of a
histone 2B-green fluorescence protein fusion protein (tetO-
H2BGFP). In the absence of the tetracycline analog
doxycycline (Dox), all of the K5-expressing cells should
express H2BGFP. Feeding Dox then inactivates tTA
subsequently turning off expression of H2BGFP. Rapidly
cycling cells quickly lose H2BGFP expression, while the label-
retaining stem cells continue to express H2BGFP, allowing
their localization in situ as well as their characterization by
FACS and subsequent culture.
To examine the kinetics of the H2BGFP reduction following
the inhibition of H2BGFP expression by Dox, thymic sections
were prepared at time 0, 2, 4, and 6 weeks after the initiation of
Dox feeding and stained with antibodies to K5 and K8 to allow
localization and characterization of the H2BGFP+ cells within
the thymic architecture. K8 is expressed in the majority of
cTECS, K5+K8+ TEC (proposed to contain TEC progenitors)
[30-33], as well as a minority of more mature UEA1hi mTECS.
Prior to Dox feeding H2BGFP expression was strong in the
K5+mTECs, as well as keratin 5-expressing cTECs at the
cortico-medullary junction (CMJ) and scattered throughout the
cortex and capsule of the thymus, as shown in the top panel of
Figure 1A. Importantly, no expression was observed in either
thymocytes or other stromal components. Our initial hypothesis
was that if a thymic stem cell/progenitor existed, it might be
localized in the band of K5+K8+ cells thought to contain the
TEC progenitors that are known to expand during thymic
regeneration [31,32]. Initial H2BGFP expression in those cells
was a prerequisite for determining if LRCs were localized in
that population.
Following the induction of Dox feeding to inhibit H2BGFP
expression within the K5+ TECs, a steady decline in H2BGFP
expression was observed, characterized by both a loss of GFP
intensity and a decrease in the frequency of GFP+ TECs
(Figure 1 A, lower 3 panels). As early as 4-weeks after Dox
was initiated, it was apparent that most of the H2BGFPhi cells
were localized to the CMJ at the border of the K8+ cTECs and
the K5+mTECs and often within K5+K8+ TECs (see Figure 1A, 4
and 6 week 400X panels). While some GFPhi cells remained
scattered in the medulla at 4 weeks the majority mTECs deep
in the medulla had reduced expression of GFP by 6 weeks.
These histology results correlated very closely with the
reduction in H2BGFP+ TECs observed when FACS analysis for
EpCAM and GFP expression was performed on dissociated
thymic tissue at each time point following Dox induction.
EpCAM is the most definitive epithelial marker used to identify
TECs [34]. GFPhi cells represent the slow cycling label-
retaining cells at later time points. GFPlow cells represent
cycling cells in the process of diluting the label, while GFP- cells
represent TECs that either never expressed H2BGFP or cells
that completely diluted the GFP due to rapid proliferation. At
time 0 the frequency of EpCAM+GFPhi TECs within the total
CD45- stroma was 1.5% (Figure 1B); it then went down to
0.4% at 2 weeks, 0.12% at 4 weeks and 0.05% at 6 weeks. An
expected increase in the GFPlow population that correlated with
the dilution of H2BGFP expression in cycling cells was also
observed. While the absolute frequencies varied across
experiments due to inherent variation in the method used to
dissociate the thymus, which results in a single cell suspension
that is differentially contaminated with CD45+ hematopoietic
cells, the relative changes were representative of 3
independent experiments. A comparison of actual numbers of
EpCAM+GFPhi cells over time, following Dox induction, showed
a consistent reduction in GFPhi cells from a high of ~2 x 104/
thymus, representing 35% of the EpCAM+ TECs, reducing by
40-60% every 2 weeks to 0.2 x 103/thymus at 6 weeks,
representing 0.4% of the EpCAM+ TECs (Figure 1C, grey bars).
A comparison of 6 and 12 weeks shows that the number of
GFPhi cells remains fairly constant, suggesting that they are
truly LRCs. The number of GFPlo cells increases initially and
correlates inversely with the decrease in GFPhi cells as
expected (Figure 1C, striped bars). The number of EpCAM+
cells remains fairly constant ranging from 5.5-9.5 x 104/thymus
(Figure 1D).
Frozen sections of thymi from 3-week old K5tTA;TetO-
H2BGFP double transgenic mice (H2BGFP mice) were
Thymic Mesenchymal Stem Cells
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prepared and stained for K5 and K8 expression. Prior to
exposure to Dox, H2BGFP+ cells were abundant in both the
cortex and medulla. H2BGFP expression was also evident in
the capsular epithelium (Figure 2A). Counter staining with anti-
K8 (red) and anti-K5 (blue) antibodies revealed that H2BGFP
fusion protein expression was restricted to K5-expressing
TECs found throughout the thymus. Importantly, no expression
was observed in either thymocytes or other stromal
components (Figure 2C and higher mag. inset). H2BGFP
expression was more restricted to the medulla in 8-14 week-old
mice (Figure 1A and 2H), reflecting the reduced expression of
K5 in the cortex as the mice progress from neonates to adults.
Dox feeding was initiated at weaning and continued for 10
weeks to allow dilution of the H2BGFP in the actively dividing
TECs. Following the 10-week Dox chase analysis of H2BGFP
expression in thymic sections revealed a dramatic reduction in
the numbers of H2BGFP+ cells (Figure 2B). Counterstaining
with K5 and K8 antibodies revealed that the H2BGFP+ label-
retaining TECs were most abundant in a ring of cells localized
at the cortico-medullary junction (Figure 2D). The white arrows
Figure 1.  Changes in H2BGFP expression within TECs in K5tTA;TetO-H2BGFP transgenic mice following a time course of
Dox feeding.  A. Thymic sections prepared at the initiation of Dox feeding and from 2-6 weeks after the start of Dox feeding
showing the reduction in H2BGFP expressing TECs. Sections were stained with anti-K8 (red) and anti-K5 antibodies (blue) to allow
localization of the H2BGFP expressing nuclei within TECs. B. Representative FACS analysis of CD45- dissociated thymic stroma
showing the frequency of EpCAM+ H2BGFP+ cells at time 0, 2, 4 and 6 weeks after the initiation of Dox feeding to inhibit H2BGFP
expression in K5+TECs. Gates from left to right in each panel show the frequency of EpCAM+H2BGFP-, EpCAM+H2BGFPlo and
EpCAM+GFPhi TECs at each time point. C. Graph shows the mean number of EpCAM+H2BGFPhi label-retaining cells and the
number of EpCAM+H2BGFPlo cycling cells per thymus at 0, 2, 4, 6 and 12 weeks after the inhibition of H2BGFP expression through
Dox feeding. Error bars are +/- the standard deviation of the mean. Results are representative of 3 independent experiments with 5
mice at each time point/experiment. D. Graph depicts the mean number of CD45- EpCAM+ TECs/thymus at 0, 2, 4, 6 and 12 weeks
after the inhibition of H2BGFP expression through Dox feeding. Error bars are +/- the standard deviation of the mean.
doi: 10.1371/journal.pone.0083024.g001
Thymic Mesenchymal Stem Cells
PLOS ONE | www.plosone.org 5 December 2013 | Volume 8 | Issue 12 | e83024
and higher magnification inset identify H2BGFP+ cells at the
junction between the K8-expressing (red) cortex and the K5-
expressing (blue) medulla. In the higher magnification inset it is
clear that the LRCs localized to the cortico-medullary junction
maintain both K5 and K8 expression.
All of the H2BGFPhi LRCs localized within the edge of the
medullary areas in thymic sections from Dox treated mice were
positive for MTS10 antibody staining, which marks the
dominant immature K5+ mTEC subset and typically surround
clusters of more mature UEA1hi CD80hi Aire+ mTECs.
K5+MTS10+ TECs define the first subset that can be identified
as mTECs in the E12 thymus [30]. The LRCs did not express
Ki67, which marks actively cycling cells (Figure 2E-white
arrows indicate the location of H2BGFPhi label-retaining cells),
supporting that the LRCs had a stem cell phenotype similar to
the slow cycling epithelial stem cells [20]. The LRCs in the
thymus were also shown to express the N-terminal truncated
isoform of P63, ΔNP63, but not the Aire transcription factor
(Figure 2F). ΔNP63 is a P53 family member transcription factor
expressed by epithelial stem cells in the skin and thought to
define keratinocyte stem cells [32,35-38], and is lost as the
cells differentiate [35,39]. P63 expression was also shown to
be critical for thymic epithelial development, as P63KO mice
exhibit a severely hypoplastic thymus [37]. The Aire
transcription factor, on the other hand, is expressed by more
mature mTECs (MHCIIhi CD80hi). The absence of Aire, which
controls promiscuous gene expression necessary for self-
tolerance, within the H2BGFP label-retaining subset argues
against the label-retaining cells being terminally differentiated
mTECs that have simply stopped dividing. This was confirmed
when similar sections were stained with UEA1 (Ulex Europeus
Agglutinin-1), which binds to most mTECs at a low level and
strongly to MHCIIhi CD80hi mature mTECs and anti-DEC205
(CD205), which labels all cTECs. Analysis of LRCs shows that
they are primarily UEA1 low or negative when they are
localized at the edge of the medulla while LRCs at the CMJ are
primarily DEC205+ supporting a cTEC phenotype (Figure 2G).
In contrast, when similar staining was performed on thymic
Figure 2.  Localization and characterization of thymic label-retaining cells in K5tTA;TetO-H2BGFP mice.  A. H2BGFP
expression in thymic section prior to Dox feeding (100X). B. H2BGFP expression in thymic section after 10-week Dox feeding. C.
Overlay of H2BGFP (green), K8 (red) and K5 (blue) expression prior to Dox feeding. White arrows show H2BGFP LRCs
concentrated at cortico-medullary junction defined by K5 and K8 staining (inset= K5, H2BGFP overlay 400X showing that H2BGFP
is restricted to K5-expressing cells). D. Overlay of H2BGFP, K8 and K5 in thymic section following 10-week Dox chase (inset: 400X
of H2BGFP LRCs stained with K5 and K8 at CMJ). E. 400x images of thymic sections showing expression of MTS10, H2BGFP,
Ki67 and merge. White arrows define position of H2BGFPhi LRCs. F. 400X images of thymic sections showing expression of
ΔNP63, H2BGFP, Aire and merge. White arrows define position of H2BGFPhi LRCs. G 400x images of thymic sections showing
staining with UEA1 PE (red) and DEC 205 Alexa 647 (pink) together with H2BGFP and Merge. H. 400x images of thymic sections
derived from K5tTA;tetO-H2BGFP mice prior to Dox feeding stained with UEA1PE (red) and DEC205 Alexa 647(Pink) together with
H2BGFP and merge.
doi: 10.1371/journal.pone.0083024.g002
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sections derived from transgenic mice that had not been fed
Dox, the GFP+ cells contained most of the mTECs including
both UEA1hi and UEA1lo cells, as well as DEC205+ cells at the
CMJ (Figure 2H) and K5+ cTEC scattered throughout the cortex
(Figure 2A & C).
Cell surface phenotype and in vitro growth potential of
thymic label-retaining cells
The advantage of the H2BGFP transgenic model lies in the
capacity to use flow cytometry to both analyze the cell surface
phenotype of the label-retaining population and to sort viable
LRCs for in vitro culture and gene expression analysis. To
characterize the cell surface phenotype of the H2BGFP-
expressing cells and follow the changes in that phenotype,
FACS analysis was performed on dissociated thymic tissue
both prior to the initiation of Dox feeding and at various times
from 6-12 weeks following the inhibition of the H2BGFP-
transgene by Dox. At each time point thymi from five mice were
pooled and dissociated prior to staining with a panel of surface
markers used to define TECs as well as stem cells. For each
analysis residual CD45+ hematopoietic cells were excluded and
then cells were gated for EpCAM expression to focus the
analysis on TECs. The EpCAM+ cells were then analyzed for
H2BGFP expression and gated for H2BGFPhi versus H2BGFPlo
cells (Figure S1 A). For each subsequent analysis the surface
expression observed at each time point in the Dox feeding time
course is shown for the total CD45- stroma, as well as for the
total GFP+, GFPlo and GFPhi cells in each subsequent panel,
respectively. The results shown are representative of 3
independent experiments.
Surface expression of MHCII and EpCAM is routinely used to
analyze dissociated thymic stroma and allows characterization
of cells into TEC and non-TEC subsets, with EpCAM defining
the TECs and MHCII allowing further distinction of MHCIIhi
mature mTECs and MHCIIlo immature mTECs and cTECs.
MHCII+EpCAM- cells represent a subset of thymic
fibroblasts[12,40], while double negative cells include the
remaining stromal components including MHCII- fibroblasts and
endothelial cells. Prior to Dox feeding the total GFP+ subset is
restricted to primarily the EpCAMhi TEC population and
contains all of the MHCII-expressing TEC subsets including
both the immature MHCIIlo and mature MHCIIhi subsets. The
GFPhi subset expresses a similar profile, however it is more
enriched in the EpCAMhiMHCIIlo immature TEC subset (Figure
S1 B). Following Dox feeding, the population of GFPhi LRCs
becomes progressively more restricted to the MHCIIlo subset
(Figure S1B, lower right panel), suggesting that the cells are
not likely to be terminally differentiated mTEC which fall in the
MHCIIhi subset.
Further analysis with UEA1 and BP1 (Ly51), which are used
to define mTECs and cTECs respectively, revealed an equal
proportion of UEA1+ mTECs and BP1+ cTECs within the total
GFP+ and GFPhi subsets prior to Dox feeding. The GFPhi LRCs
gradually changed to a population that was more enriched in
BP1+ cTECs with a small population of UEA1+ mTECs following
6 weeks of Dox feeding (Figure S1 C). These results correlated
well with our histology data showing that the H2BGFP bright
cells were primarily restricted to the CMJ within UEA1dim
immature mTECs and DEC205+ K5+K8+ mTECs. Analysis of
MHCII together with CD80 revealed a similar trend, with the
initial GFP+ and GFPhi cells expressing a diverse TEC
phenotype including both CD80+ mature mTECs and CD80-
immature mTECs and cTECs with the LRCs gradually showing
a reduction in MHCIIhi CD80hi cells but still containing 20%
CD80+ cells at the end of 6 weeks of Dox feeding (Figure S1
D). These CD80+ cells could represent terminally differentiated
mTECs that retained the label because they stopped dividing
however, their lower MHCII expression level and slightly
reduced CD80 expression more likely support an immature
mTEC or cTEC identity.
Stem cell antigen (Sca1/Ly6) is the most recognized
hematopoietic stem cell (HSC) marker in mice [41-45]. Sca1
has also been identified in a number of non-hematopoietic
tissues [46], however, and can be used to enrich for progenitor
populations other then HSCs including epithelial stem cells
[20,47] and MSCs [16]. Antibodies against Sca1, together with
antibodies against the alpha-6 (CD49F) and beta-1 (CD29)
integrins, have been used in combination to define MSCs and
epithelial stem cells within the stem cell niche. Analysis of Sca1
expression on dissociated thymic stroma from a 3-month-old
mouse revealed a surprising abundance of Sca1 expression on
a variety of TEC subsets (Figure 3). After gating for CD45-
stroma, analysis with MHCII and EpCAM allowed separation of
the EpCAM-expressing TEC subsets including the
MHCIIhiEpCAMhi mature mTECs and the MHCIIloEpCAMhi
subset containing both immature mTECs and cTECs. The
population of MHCIIlo/negEpCAMlo TECs that is more abundant
in older animals and appears in mice fed Dox for longer time
periods was also analyzed (Figure 3A). The MHCIIhiEpCAMhi
mature TEC subset was primarily Sca1-, while the less mature
MHCIIloEpCAMhi subset, which contains the LRCs, was
predominantly Sca1+. The MHCIIlo/negEpCAMlo TEC subset
contained a mixture of 35-40% Sca1+ and 60-70% Sca1- TECs
(Figure 3B). No expression of Sca1 was detected in the MHCII-
EpCAM- stromal cells suggesting that Sca1 expression is
restricted to EpCAM-expressing TECs in the CD45- thymic
stroma (data not shown). Analysis of CD49F and CD29
expression on the Sca1+ population derived from each TEC
subset revealed that both the MHCIIhiEpCAMhi and
MHCIIloEpCAMhi TEC populations contained primarily
CD49FhiCD29+ cells, while the MHCIIlo/negEpCAMlo subset
contained both a CD49FhiCD29+ subset and a CD49FloCD29+
population (Figure 3C). In contrast the Sca1- population in all
TEC subsets contained primarily CD49Flo CD29- cells. These
results were representative of three independent experiments.
We next sought to determine if the H2BGFP+ LRCs
expressed Sca1, similar to stem cell/progenitor populations in
other tissues. Following gating for CD45- EpCAM+ stroma the
H2BGFP-, H2BGFPlo and H2BGFPhi subsets derived from sets
of five mice, isolated before and up to 8 weeks after the
initiation of Dox feeding, were analyzed for Sca1 expression
(Figure 3E). With increased time after Dox induction, both the
GFPhi and GFPlo subsets became progressively enriched in
Sca1+ TECs, with the GFPhi population being exclusively Sca1+
cells. The presence of Sca1 on the LRC subset supports an
immature stem cell/progenitor phenotype. With the increase in
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age inherent in the K5tTA; tetO-H2BGFP mice, fed Dox for
more than 8 weeks to ensure the dilution of the H2BGFP label,
an increase in the MHCIIloEpCAMlo TEC subset was observed
including GFP+ cells. Analysis of GFP-expressing TECs
following a 10-week Dox inhibition revealed the appearance of
increased numbers of the MHCIIlo/neg EpCAMlo subset,
particularly in the GFPlo subset (Figure 3F). This population
was not abundant in the GFP-expressing cells in younger mice
fed Dox for 6 weeks or less, suggesting that the cells are
derived from GFPhiEpCAMhi cells. Analysis of the H2BGFP+
LRCs within the MHCIIlo EpCAMhi and MHCIIlo/-EpCAMlo
 subsets for expression of Sca1 showed that after 10 weeks of
Dox feeding, both populations were enriched in Sca1+ cells
(Figure 3G, upper 2 panels). Further analysis of the Sca1+
subsets for CD49F and CD29 expression revealed that the
MHCIIlo/- EpCAMlo Sca1+ population was enriched in a the
unique CD49FloCD29+ subset (Figure 3G lower 2 panels) which
we will later demonstrate contains in vitro growth potential and
the capacity to generate cell lines with characteristics of MSCs.
E12-E15 fetal epithelial cells contain a TEC progenitor
phenotype and are able to form reconstitution thymic organ
cultures (RTOCs), which are able to form functional thymic
Figure 3.  LRCs become progressively enriched in Sca1+TECs and contain a unique subset of
MHCIIloEpCAMloSca1+CD49FloCD29+ cells.  A. Gating strategy for analysis of TEC subsets defined by MHCII and EpCAM
expression in C57BL/6J dissociated thymic tissue. B. Sca1 expression within the 3 subsets defined by MHCII and EpCAM
expression. C. Characterization of CD49F and CD29 expression within the Sca1+ TECs defined by MHCII and EpCAM expression.
The MHCIIloEpCAMlo Sca1+ TECs contain a unique CD49FloCD29+ subset not found in other populations defined by MHCII and
EpCAM expression or within Sca1- TEC subsets. D. Characterization of CD49F and CD29 expression within the Sca1- TECs
defined by MHCII and EpCAM expression. E. Sca1 expression within the subsets of LRCs during an 8-week Dox time course. F.
Characterization of EpCAM+ LRCs following 10-week Dox feeding. Upper panel shows gating used to define H2BGFPhi and
H2BGFPlo subsets of LRCs. Middle 3 panels show characterization of total EpCAM+ as well as H2BGFPlo and H2BGFPhi LRCs
using BP1 to define cTECs and UEA1 to define mTECs. Lower 3 panels show expression of MHCII and EpCAM in the same 3
populations. G. H2BGFP+ LRCs were separated into MHCIIloEpCAMhi and MHCIIlo/- EPCAMlo subsets and then analyzed for Sca1
expression (upper row). Sca1+ cells in each population were then analyzed for CD29 and CD49F. Results were representative of 5
independent experiments.
doi: 10.1371/journal.pone.0083024.g003
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tissue when transplanted and grown under the kidney capsule
of nude or syngeneic mice [48,49]. H2BGFP label-retaining
epithelial stem cells, isolated from the skin, are able to form
new hair follicles and skin [20]. To determine if LRCs sorted
from the adult mouse thymus contained a population of TEC
progenitors, 10,000 EpCAM+H2BGFP+ LRCs were sorted from
10-week Dox fed double transgenic mice and reaggregated
with 2x105 E15.5 dissociated fetal stroma and 2 x105 sorted DN
thymocytes. Removal from Dox treatment allows re-expression
of the H2BGFP transgene and facilitates identification of the
adult derived cells in the reaggregate. After 2 days in culture on
transwell plates the reaggregates containing H2BGFP+ adult
cells were transplanted under the kidney capsule of nude mice
and allowed to grow for 4 weeks. While in all cases functional
thymic tissue was present on the kidney due to the presence of
fetal epithelial cells, significant numbers of H2BGFP expressing
cells were only detected in 1 out of 12 reaggregates (data not
shown) suggesting that they either do not contain a TEC
progenitor population or that the adult stem cells are not able to
compete or do not have the right environment to expand when
placed in the fetal environment. We were encouraged,
however, because in the one reaggregate that contained
significant H2BGFP+ TECs the cells had clearly expanded and
were expressing both cortical and medullary TEC markers. We
chose not to present the results here because of the difficulty in
reproducing the result, but it justifies further characterization of
the LRC population. Forming reaggregates with only sorted
adult cells was not possible due to the rare nature of the LRCs
following Dox treatment and the large number of TECs required
to consistently form reaggregates.
Epithelial stem cells, as well as mesenchymal stem cells
isolated from other tissues, share the capacity to grow and
form colonies in culture [16,20,50,51]. When CD45- EpCAMlo
MHCIIlo Sca1+H2BGFP+ LRCs were sorted to greater than 95%
purity from dissociated 10-week Dox fed thymic tissue, and
plated at a density of 3 x 104 cells/plate they were shown to
have a limited capacity to form colonies and grow when
cultured in thymic stromal medium in the presence of LIF, EGF
and FGF (Figure 4A). Counting the number of colonies formed
revealed that the mean frequency of cells capable of forming
clones was 0.04% (Figure 4I). In contrast, Sca1+H2BGFP+
CD45-EpCAMhiMHCIIlo cells, which are the dominant population
of the GFPhi LRCs, exhibited significantly less growth potential
(0.002% mean, P=0.0002) under the same conditions (Figure
4B). Limited or no growth potential was also observed with
sorted total EpCAM+ Sca1-, and EpCAMhiMHCIIhi Sca1+ (data
not shown).
We next compared the ability of the two subsets of Sca1+
thymic label-retaining cells to continue to grow in culture and
generate cell lines. Sorted CD45- EpCAMlo MHCIIlo Sca1+
H2BGFP+ LRCs exhibited rapid in vitro growth when cultured in
thymic stromal medium. The EpCAMlo LRCs had reached full
confluence within 4 days after sorting, when plated at 5 x 103
cells/well in 96 well plates coated with laminin, with many cells
maintaining H2BGFP expression (Figure 4C & E). In contrast,
sorted MHCIIint EpCAMhi Sca1+LRCs survived in culture and
maintained stronger H2BGFP expression but only divided 1 or
2 times before halting their growth under identical conditions
(Figure 4C & D). The reduction in H2BGFP expression
continued in the EpCAMlo cells until it was virtually
undetectable under the fluorescence microscope at later
passages. The morphology of the cells appeared similar to
mesenchymal cells. Since the LRCs cells were derived from a
Tetoff double transgenic mouse, subsequent culture in growth
medium deficient in Dox allows for re-expression of H2BGFP
driven by the K5 promoter. The expression of H2BGFP in the
rapidly expanding population further confirms the epithelial
origin of the LRCs, since H2BGFP expression in K5tTA;TetO-
H2BGFP double transgenic mice was restricted to K5-
expressing TECs (Figure 1). The reduction in GFP expression
observed following longer culture and cloning could be the
result of loss of epithelial characteristics and reduced K5-
promoter activity.
Analysis of the MHCIIintEpCAMhi and MHCIIlo/-EpCAMlo GFP+
subsets for Sca1, CD49F and CD29 expression, following 10-
weeks of Dox feeding, revealed that while both populations
were predominantly Sca1+, they differed in their expression of
CD49F. After gating for Sca1+ cells, both the EpCAMhi and
EpCAMlo GFP+ subsets contained a population expressing high
levels of both CD49F and CD29, while more than 50% of the
MHCIIlo/- EpCAMloSca1+ population exhibited a CD49FloCD29+
phenotype (Figure 3G). We reasoned that this unique
population might explain the enhanced in vitro growth of the
MHCIIlo/-EpCAMlo Sca1+ LRC subset. Sorted MHCIIlo/-EpCAMlo
Sca1+CD49FloCD29+ exhibited enhanced colony forming
potential (Figure 4G) with a mean colony forming frequency of
0.14% +/- 0.04% SD (Figure 4I). In contrast, almost no growth
was observed in either the MHCIIlo/-EpCAMlo
Sca1+CD49FhiCD29+ or MHCIIintEpCAMhi Sca1+CD49Fhi CD29+
populations (Figure 4H & I). Together these results
demonstrate that the label-retaining TEC subset with growth
potential has a MHCIIlo/-EpCAMlo Sca1+CD49floCD29+
phenotype. Low-level expression of MHCII would be expected
for more immature TECs, while the expression of Sca1, CD49F
and CD29 is similar to the phenotype of label-retaining stem
cells identified in the skin [20].
LRCs isolated from the postnatal thymus maintain low-
level H2BGFP expression and exhibit a cell surface
phenotype similar to mesenchymal stem cells
The fast growth rate and morphology suggested that the
LRCs able to grow in vitro were similar to MSCs. We next
sought to determine if the LRCs also shared molecular and
functional characteristics of MSCs. After expanding the freshly
sorted EpCAMlo thymic LRCs for five passages in thymic
stromal medium, one of these lines TMSC7 was stained with a
panel of antibodies that define the cell surface profile of MSCs.
This analysis revealed that the cells maintained low-level
expression of H2BGFP, showing they were derived from LRC
that had expressed keratin 5. H2BGFP expression is also
confirmed in the fluorescence images shown in Figure 4.
TMSC7 also maintained low-level surface expression of
EpCAM, the most definitive marker of thymic epithelial cells, as
well as low level MHCII expression. In addition, the culture
expanded thymic LRCs maintained strong and consistent
surface expression of Sca1, CD29, CD44, CD49F, CD90 and
Thymic Mesenchymal Stem Cells
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PDGFRα Low-level expression of CD34, PDGFRβ and SSEA
was also detected. (Figure 5). TMSC lines also consistently
expressed CD106 (data not shown). This surface profile is very
similar to the surface profile of MSC lines derived from bone
marrow and a variety of other tissues [16,52].
EpCAMlo Thymic LRCs expanded in vitro exhibit the
capacity to differentiate into osteoblasts, adipocytes
and chondrocytes similar to MSCs
Based on the similarities to MSCs isolated from other
tissues, we next investigated whether culture expanded sorted
EpCAMlo LRCs displayed MSC-like multipotency. MSCs
derived from a variety of tissues are routinely characterized by
their ability to differentiate into a number of distinct lineages
including osteoblasts, adipocytes and chondrocytes [16,52].
After two weeks under culture conditions that promote
Figure 4.  In vitro growth potential of H2BGFP LRCs.  Methylene blue stained colonies derived from FACS sorted CD45-
EpCAMlo MHCIIlo/-Sca1+H2BGFP+ LRCs (A) or CD45-MHCIIintEpCAMhi Sca1+ H2BGFP+ stroma (B). C. Merge of H2BGFP
expression and phase contrast image of expanded EpCAMloMHCIIlo/- H2BGFP+ LRCs 1 week after sorting, demonstrating dramatic
in vitro growth. D. Merge of H2BGFP expression and phase contrast image showing limited expansion of EpCAMhi MHCIIintH2BGFP
+ LRCs 1 week after sorting. E. H2BGFP expression in same field as C. F. H2BGFP expression in same field as D. These results
are representative of 3 independent experiments performed with 10-12 week Dox fed H2BGFP mice. Methylene blue stained
colonies derived from FACS sorted CD45-MHCIIlo/-EpCAMlo Sca1+CD49Flo CD29+ (G) or CD45-MHCIIintEpCAMhiSca1+CD49FhiCD29+
stroma (H) derived from WT C57BL/6J mice. I. Colony forming potential of sorted LRCs and defined TEC subsets sorted from
dissociated thymus derived from postnatal C57BL/6J mice. Error bars show standard deviation of means calculated from 5
independent experiments. P values are derived by comparison of colony forming potential of sets of populations using T test.
doi: 10.1371/journal.pone.0083024.g004
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osteogenesis, culture expanded EpCAMlo LRCs displayed
abundant mineral deposits, detected with alizarin red S
staining, indicative of osteogenesis (Figure 6A, left). The
cultures showed high alkaline phosphatase activity, also
characteristic of osteoblasts [52] (Figure 6A, right). Culture
expanded EpCAMlo LRCs maintained in medium that allowed
for in vitro growth showed no evidence of alizarin red S staining
mineral deposits or alkaline phosphatase activity (data not
shown). When cultured for two weeks in adipogenic conditions,
very limited differentiation of adipocytes was observed.
However, when cultured in Keratinocyte Serum Free Medium
with low calcium and EGF, cultured EpCAMlo LRCs
differentiated into adipocytes indicated by the abundance of
lipid deposition detected with Oil Red O (Figure 6B, left). When
similar cultures were performed in the presence of PW9662, a
PPARγ inhibitor known to limit adipogenesis, the number of oil
red O positive adipocytes was dramatically reduced (Figure 6B,
right). Finally, when EpCAMlo LRCs were grown for three
weeks in chondrogenic differentiation medium, chondro-
nodules containing mucin-secreting cells detected by Alcian
blue staining were observed. These data show that the cells
maintain the capacity to differentiate into chondrocytes (Figure
6C).
Taken together, the results presented thus far suggest that
EpCAMlo LRCs isolated from the postnatal thymus express a
phenotype that is very similar to MSCs, including their cell
surface phenotype, ability to expand in culture and their ability
to differentiate into multiple lineages in vitro. While not a clonal
cell line at this point in the analysis, the uniform staining pattern
observed for each surface marker together with the high
frequency of the cells able to differentiate suggests that the
only cells to grow in vitro express a uniform MSC phenotype.
Generation of Clonal Thymic Mesenchymal Stem Cell-
like lines from postnatal WT mice
We next sought to produce long-term clonal cell lines derived
from WT mice utilizing the phenotype determined from analysis
of the H2BGFP LRCs described above. Thymi from 8-week old
to 6-month old C57BL/6J mice were dissociated and subjected
to partial depletion of hematopoietic cells using CD45 magnetic
beads. The resulting stroma enriched population was then
stained with antibodies against CD45, MHCII and EpCAM as
well as Sca1, CD49F and CD29, identical to the analysis
shown in Figure 3A-D. After gating for CD45- cells to exclude
remaining hematopoietic derived populations, analysis for
EpCAM and MHCII allows for distinction of the MHCIIlo/-
EpCAMlo population that exhibited enhanced growth potential
(Figure 4A). This subset was then gated for the
Sca1+CD49FloCD29+ subset. Sorted control populations
included the Sca1+ MHCIIlo/- EpCAMlo CD49Fhi CD29+ and the
Sca1+MHCIIlo EpCAMhi CD49Fhi CD29+ subsets. All subsets
were sorted to greater than 94% purity. Only the MHCIIlo/-
EpCAMlo Sca1hiCD49FloCD29hi showed significant in vitro
growth potential and was able to generate long term clonal cell
lines (Figure S2), supporting our observations with the LRCs
sorted from H2BGFP mice. Postnatal MHCIIlo/-EpCAMlo
Sca1hiCD49floCD29hi thymic stromal cells, isolated from 8-week
to 6-month old mice, exhibit in vitro growth potential and can be
consistently used to generate thymic stromal lines resembling
MSCs.
Figure 5.  Culture expanded CD45- MHCIIlo/-EpCAMlo Sca1+ CD49FloCD29+H2BGFP LRCs maintain a surface phenotype
similar to mesenchymal stem cells.  After expanding sorted EpCAMlo LRCs for 5 passages in vitro, their cell surface profile for a
panel of TEC and mesenchymal stem cell surface proteins using flow cytometry. Overlay histograms show a comparison of staining
for each antibody including EpCAM, MHCII, H2BGFP, Sca1, CD49F CD29, CD44, CD34, PDGFRα PDGFRβ, CD90 and SSEA in
open histograms with the relevant isotype control antibody conjugated to the same fluorochrome in gray shaded histograms. The
negative control for H2BGFP expression was TMSCs derived from C57BL/6J mice.
doi: 10.1371/journal.pone.0083024.g005
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Figure 6.  H2BGFP+ LRCs cultured in vitro exhibit the
capacity to differentiate into adipocytes, osteoblasts and
chondrocytes.  A. (Left panel), Alizarin red staining of mineral
deposits in culture-expanded FACS sorted CD45-
Sca1+EpCAMlo MHCIIloH2BGFP LRCs following 2-weeks in
conditions that promote Osteogenesis; (Right panel), alkaline
phosphatase activity characteristic of osteocytes, detected with
DAB. B. Abundant oil red+ cells following 2 weeks of culture in
adipogenesis conditions (inset shows 400X image of Oil red
stained lipid deposits). C. Section of chondro-nodule stained
with Alcian blue to detect mucin secreted by chondrocytes.
doi: 10.1371/journal.pone.0083024.g006
Gene Expression Profile of Thymic Mesenchymal Stem
Cell-like Lines
Seven independent clonal thymic stromal lines with
properties of MSCs (TMSC) have been grown in culture for up
to 25 passages. These cell lines have maintained many
characteristics of stem cells, as well as expression of genes
associated with TEC development. When maintained in MEMα
with LIF, EGF, FGF and 10% FBS medium, these cell lines
exhibit a mesenchymal-like morphology that becomes more
pronounced with passage (Figure S2 A & B). FACS analysis of
two of those lines (TMSC7-10 and TMSC2-1), performed after
10 passages for the presence of the TEC markers EpCAM and
MHCII, together with a panel of surface markers typically
expressed on MSCs, revealed biphasic low level expression of
EpCAM in TMSC7-10 while only a small subset TMSC2-1
expressed EpCAM. Limited expression of MHCII was observed
in either TMSC line. EpCAM is the most definitive surface
marker of TECs and while its expression was variable in
intensity among the clones tested we consistently observed a
biphasic profile with a small number of cells expressing higher
levels of EpCAM. MHCII expression is typically lost from TECs
upon removal from the 3D microenvironment of the thymus.
Analysis with MSC markers revealed expression of stem cell
antigen-1 (Sca1), hematopoietic cell E-selectin/L-selectin
ligand (H CELL/CD44), β1 integrin (CD29), α6 integrin
(CD49F), Thy1 (CD90), platelet derived growth factor receptor
α & β (PDGFRα& β, lacto-glycolipid expressed on murine
embryonic stem cells (SSEA-1), together with the absence of
CD34 (Figure S3). With the exception of the low-level biphasic
expression of the TEC marker EpCAM, the cell surface profile
of both TMSC clones are identical to that reported on MSCs
isolated from other tissues [16,50,52].
To further characterize the TMSC lines, a gene expression
profile was performed using a panel of primers specific for stem
cell markers and transcription factors, as well as for genes
typically associated with TEC development and function. RT-
PCR of RNA isolated at passage 5 from TMSC7 prior to limiting
dilution cloning, revealed that TMSCs maintained expression of
the core transcriptional regulators that have been reported to
be active in pluripotent cells including nanog, octamer-binding
transcription factor 4 (Oct4) and sex determining region Y-2
(Sox2) [53], as well as a number of genes associated with the
maintenance of pluripotency or early endoderm development
including genesis/forkhead box D3 (FoxD3) [54], leucine-rich
repeat-containing G-protein coupled receptor 5 (Lgr5) [55],
forkhead box protein A1 (FoxA1) [56], Cdx1 [57], stella/
developmental pluripotency associated 3 (Dappa3) [58] and
undifferentiated embryonic cell transcription factor 1 (UTF1)
[59]. TMSC lines also expressed genes reported to be
important for TEC development including the transcription
factors eyes absent 1 (EYA1), paired box gene 9 (PAX9) and
forkhead box protein N1 (FOXN1) [60,61]. In addition, TMSCs
maintained expression of Notch ligands delta-like ligand 1
(DLL1), delta-like ligand 4 (DLL4) and jagged1 (Jg1), Wnts
including Wnt4 and Wnt10b, as well as EpCAM and MHCII
(Figure S3 B). These genes are more typically associated with
TECs within the 3D thymic microenvironment. Together, this
gene expression profile suggests a population of cells that are
Thymic Mesenchymal Stem Cells
PLOS ONE | www.plosone.org 12 December 2013 | Volume 8 | Issue 12 | e83024
unusual in their co-expression of both stem cell markers and
genes more typically associated with more mature TECs and
may support a rather immature or pluripotent phenotype for
TECs in general.
Following two rounds of limiting dilution cloning, quantitative
PCR was performed for the TMSC7-10 line after 16 passages
and compared with freshly sorted TEC subsets including the
MHCIIlo EpCAMlo Sca1+CD49Flo CD29+ subset, from which
TMSC lines have been consistently derived. Highly purified
(>95%) sorted MHCIIlo EpCAMlo Sca1+CD49Flo CD29+ TECs
exhibit very limited expression of the most definitive TEC
markers Foxn1 and EpCAM; however, they exhibited a 2.5 and
6 fold increase in the stem cell markers Nanog and Sox2,
respectively, possibly contributing to their capacity to grow in
culture and generate cell lines. Surprisingly, TMSC7-10
showed low-level but dramatically reduced expression of the
stem cell markers Nanog, Oct4 and Sox2 and no maintenance
of the TEC markers Foxn1 and EpCAM after longer in vitro
culture (Figure S3 C) suggesting that these stem cell genes
may not be responsible for the maintenance of pluripotency in
TMSC lines and that the culture conditions used to maintain the
TMSCs result in the loss of TEC characteristics with time. All
results were normalized to the MHCIIint EpCAMhi subset known
to contain both cTECs and immature mTECs.
Clonal TMSC lines maintain the capacity to differentiate
into multiple mesenchymal derived lineages
The most definitive proof of MSC identity is the capacity to
differentiate in to multiple Mesenchymal lineages under
appropriate conditions. To determine if the TMSC lines, derived
from EpCAMlo MHCIIlo Sca1+CD49FloCD29hi thymic stromal
cells sorted from 6-month old postnatal mice, maintained the
capacity to differentiate into mesenchymal lineage cells, the
TMSC7-10 line was subjected to the same culture conditions
that promoted differentiation of EpCAMlo MHCIIlo
Sca1+H2BGFP LRCs (Figure 6). When subjected to conditions
that induced adipogenesis in cultured thymic LRCs, TMSC7-10
differentiated into adipocytes as indicated by the presence of
oil red O staining oil droplets within a large number of the
cultured cells (Figure 7B and inset). TMSC7-10 control cultures
grown in thymic stromal medium showed no evidence of oil red
stained adipocytes (Figure 7A). When late passage cultures of
TMSC7-10 cells are allowed to reach high density in thymic
stromal medium a small number of cells appear to differentiate
into adipocytes, suggesting a natural tendency to differentiate
toward the adipocyte lineage, similar to aging TECs [9].
Identical to cultured thymic LRCs, TMSC7-10 were also able
to differentiate into osteocytes (Figure 7D) and chondrocytes
(Figure 7E) when subjected to conditions that promote
osteogenesis and chondrogenesis, respectively. Cultures of
TMSC7-10 lines subjected to growth conditions that promote
osteogenesis also stained for abundant expression of alkaline
phosphatase, similar to the results shown for cultured LRCs in
Figure 6 (data not shown). Identical results were obtained in 3
independent experiments and with 3 independent TMSC
clones. Therefore, culture of thymic stromal cells defined by the
EpCAMloMHCIIlo Sca1+CD49floCD29hi phenotype and identified
as a subset of thymic LRCs, enriches for a population of
postnatal thymic stromal cells with properties similar to MSCs.
Sorted EpCAMloMHCIIlo Sca1+ TECs used to derive
TMSCs contribute to reaggregates with E15.5 fetal
thymic stroma and are maintained after transplant
under the nude mouse kidney capsule as TECs
The multipotency of TMSCs suggested that they might
contribute to the maintenance of postnatal thymic epithelial
microenvironments. To test this hypothesis, the
EpCAMloMHCIIlo Sca1+ thymic stromal subset, that consistently
gave rise to TMSC lines in vitro, was sorted from C57BL/6J
eGFP mice that ubiquitously express GFP in all cells.
EpCAMhiMHCIIint Sca1+ and EpCAMhiMHCIIhi Sca1+ subsets
with no in vitro growth potential were also sorted as controls.
Cells were sorted to greater than 95% purity (data not shown).
The sorted GFP-expressing subsets were mixed with
dissociated thymocyte-deleted fetal stroma derived from E15.5
C57BL/6J WT mice and allowed to form reaggregates for 48hrs
on polycarbonate filters supported on transwell plates.
Functional reaggregates were photographed in phase and with
488nm excitation to show that the sorted eGFP adult stromal
subsets were maintained in the reaggregates (Figure 8A-B). All
of the sorted eGFP-expressing adult subsets were present
within the reaggregate cultures at 48hrs, however the
EpCAMloMHCIIlo Sca1+ subset was more abundant and the
cells appeared to have more cytoplasmic processes (Figure 8
A, right panel) when compared with control subsets like the
EpCAMlhiMHCIIhi Sca1+ population (Figure 8B, right panel).
These results were representative of three independent
experiments performed with 2-3 reaggregates of each type for
each experiment. Reaggregates attempted with multiple clonal
GFP-expressing TMSC lines alone failed to make functional
reaggregates with sorted DN thymocytes, possibly due to loss
of TEC characteristics after prolonged culture. In reaggregates,
generated by mixing fetal thymic stroma and limited numbers of
GFP-expressing TMSC lines the GFP+ cells that remained
were never found to co-express keratin suggesting that the
cells may have lost the capacity to differentiate into TECs or
that the fetal environment is not appropriate for their
differentiation into TECs.
Reaggregates containing sorted EpCAMloMHCIIlo Sca1+
eGFP+ adult stromal cells were then surgically transplanted
under the kidney capsule of nude mice. Following 3 weeks of
growth under the kidney capsule, the kidneys were harvested,
embedded, and cryostat sections were prepared. Sections
were stained with anti-GFP to detect GFP expressing adult
stromal cells maintained in the expanded reaggregate thymus,
as well as a panel of antibodies used to characterize both
thymocytes and the thymic stroma.
To confirm that the reaggregate thymi observed growing
under the kidney capsule were functional, sections were
prepared and stained with anti-CD4 and anti-CD8 to confirm
the presence of developing thymocytes recruited from the nude
mouse bone marrow (BM), and to characterize the distribution
and developmental state of the thymocytes present. When
thymic sections are stained with DAPI, cortical areas have a
higher density of nuclei due to the abundance of DP
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Figure 7.  Clonal TMSC lines maintain the capacity to form Adipocytes, Osteoblasts and Chondrocytes in vitro.  A. TMSC7
cell line cultured in MEMα medium supplemented with EGF, FGF and LIF and then stained with Oil Red O; B. Oil Red S staining of
TMSC7 cultured in KSFM + 10% FBS + EGF which induced adipogenesis (inset 400X image of Oil Red O staining droplets of lipid);
C. Alizarin Red S staining of TMSC7 cultured in control medium; D. Alizarin Red S staining of mineral deposits in TMSC7 cultured in
osteogenesis differentiation medium; E. Alcian Blue staining of frozen section of Chondro-nodule following culture of TMSC7
cultured in chondrogenesis conditions. (Mag. A - D, 100X; inset and E 400X) Similar results for all differentiation assays were
obtained in a minimum of 3 experiments and with multiple TMSC lines.
doi: 10.1371/journal.pone.0083024.g007
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Figure 8.  Sorted EpCAMlo MHCIIlo Sca1+ TECs contribute to thymic reaggregates after transplant under the nude mouse
kidney capsule.  A. 40x phase and GFP fluorescence images of a reaggregate thymus created from sorted EpCAMloMHCIIloSca1+
TEC derived from B6eGFP mice mixed with dissociated B6 E15.5 fetal thymus. B. 40x phase (left) and GFP fluorescence images
(right) of a reaggregate thymus created from sorted EpCAMlhiMHCIIhiSca1+ TEC derived from B6eGFP mice mixed with dissociated
B6 E15.5 fetal thymus. C. 200X confocal fluorescence images of a 10μm frozen section prepared an EpCAMloMHCIIloSca1+
reaggregate thymus under the kidney capsule of a nude mouse stained with DAPI (left) and anti CD4PE (red), anti-CD8APC (blue)
and anti-GFP FITC (green). The kidney is clearly visible on the lower right of each panel. D. Localization of sorted EpCAMlo MHCIIlo
Sca1+ GFP+ cells retained in sections of reaggregate thymus grown under nude mouse kidney capsule for 3 weeks. Arrows indicate
the location of GFP+ cells in each panel. Sections were stained with anti Keratin 8-PE (red), antiGFP-FITC (green), UEA1 APC
(pink) and DAPI (blue). Upper 5 cells were K8+UEA1+ while lower 3 only expressed K8. E. Sections of reaggregates containing
EpCAMloMHCIIloSca1+ adult TECs stained with UEA1PE (red), Anti-GFP FITC (green) DEC205 Alexa647 (pink) and DAPI (blue). In
the last merged panel GFP+ adult cells included UEA1+ and UEA1- mTECs, as well DEC205+ cTECs. F. Localization of sorted
EpCAMhi MHCIIhi Sca1+ GFP+ cells retained in sections of reaggregate thymus grown under nude mouse kidney capsule for 3
weeks. Arrows indicate the location of GFP+ cells in each panel. Sections were stained with anti Keratin 8-PE (red), antiGFP-FITC
(green), UEA1 APC (pink) and DAPI (blue). White C= cortex, White M= medulla in all panels.
doi: 10.1371/journal.pone.0083024.g008
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thymocytes, while medullary areas exhibit a lower density of
staining due to the reduced number of mature CD4 and CD8
SP. This was clearly evident in all of the reaggregate thymi
produced (Figure 8C, left panel). Staining with CD4 and CD8
confirmed the presence of abundant DP thymocytes (purple) in
cortical areas as well as CD4SP (red) and CD8SP (blue) in
medullary areas, confirming the capacity of the reaggregate
thymus to attract T cell progenitors from the BM and support T
cell development to the mature SP stage. GFP+ cells derived
from the EpCAMloMHCIIloSca1+ cells were seen in both
medullary and cortical areas and in some cases were found
included in GFP-expressing clusters of cell that could represent
expanding cells (Figure 8C, inset)
The higher abundance of GFP-expressing cells observed in
the reaggregates after the 2 day in vitro culture (Figure 8A) was
maintained in the reaggregates created with the
EpCAMloMHCIIlo Sca1+ subset, with the majority of the GFP-
expressing cells being localized in the medulla or cortico-
medullary junction (Figure 8D & E). While dramatic expansion
of the GFP-expressing adult cells was not apparent, staining
with anti-K8 (expressed in the majority of cTECs and a subset
of mTECs) as well as the mTEC marker UEA1, demonstrated
that the GFP-expressing cells remaining after 3 weeks had
become both UEA1+K8+ TECs similar to mature mTECs (Figure
8D upper 4 arrows), as well as an equal or higher number of
K8+UEA1- cells, which might be cTECs or K5+K8+ putative TEC
progenitors. Further characterization with the cTEC specific
DEC205 antibody together with UEA1 revealed an abundance
of GFP-expressing UEA1lo/neg cells in the medulla (likely to be
immature mTECs), as well as DEC205+ cTECs localized at the
cortico-medullary junction. In contrast to these results observed
in reaggregates made with the EpCAMloMHCIIlo Sca1+subset,
none of the limited number of GFP-expressing cells that were
maintained in reaggregates created with sorted control
populations expressed an epithelial phenotype (Figure 8F), as
they did not express K8, DEC205, MTS10 or bind UEA1. Most
of the GFP+ cells that remained appeared to be localized within
epithelial free regions of the thymus or possibly lining or within
blood vessels (Figure 8F and inset). The requirement for the
use of the rabbit polyclonal anti-GFP antibody to detect the
GFP-expressing cells limited our capacity to counter-stain with
rabbit anti-K5 or anti-K14 antibodies, as no other anti-GFP
antibodies or keratin antibodies were functional and specific in
our hands.
Discussion
Utilizing the slow cycling characteristics typically associated
with stem cells, this study set out to isolate a population of
TECs with properties of stem cells from the postnatal thymus.
The K5tTA;TetO-H2BGFP tetracycline-regulated transgenic
model was utilized to facilitate the use of flow cytometry for
characterization and subsequent sorting of LRCs for in vitro
growth potential and gene expression. Prior to Dox induced
inhibition of H2BGFP expression, immunofluorescence
microscopy revealed that H2BGFP transgene expression was
restricted to K5-expressing TECs and labeled the dominant
K5+mTEC subset, as well as K5K8DP Dec205+ cTECs and
capsular epithelium. Following a 6 to 12-week Dox chase, the
expected reduction in H2BGFP expression was observed,
leaving a small population of H2BGFPhi LRCs at the cortico-
medullary junction and H2BGFPlow LRCs primarily within the
medulla. Analysis of these LRC populations by histology
revealed that they expressed immature TECs markers (MTS10
and K5 or K5K8DP) as well as the N-terminal deleted isoform
of P63 (ΔNP63). ΔNP63 identifies keratinocyte stem cells [36]
and is essential for the proliferative potential of stem cells in
stratified epithelia [37]. ΔNP63 is expressed in a large
percentage of TECs and loss of P63 results in a severely
hypoplastic thymus [37]. A larger population of H2BGFPdim
LRCs cells was also observed and persisted for at least 8
months when mice were fed Dox for an extended time. This
population was most abundant in the K5-expressing thymic
medulla, however it appeared to express a more diverse
phenotype including some cells that had reduced keratin
expression, suggestive of epithelial mesenchymal transition
(EMT) (manuscript in preparation). Alternatively, the dim cells
may represent cells that have been derived from the brighter
LRCs that exhibit reduced H2BGFP expression due to a high
rate of proliferation.
Analysis of the thymic LRCs using FACS revealed a
surprising abundance of H2BGFP+ LRCs and confirmed our
histological observations with a small number H2BGFPbright
cells and a larger percentage of H2BGFPdim cells, even after
suppression of H2BGFP expression for eight months. Further
analysis of the LRCs using EpCAM and MHCII expression,
which define TECs, revealed two distinct subsets of LRCs
including both EpCAMhi MHCIIint and EpCAMlo MHCIIlo subsets.
The H2BGFPhi subset contained primarily EpCAMhi MHCIIint
TECs while the H2BGFPdim subset contained primarily EpCAMlo
MHCIIlo TEC subsets. Initial analysis of the growth potential of
EpCAM+ LRCs compared with EpCAM+ non-label-retaining
cells demonstrated enhanced in vitro growth of the LRCs.
Culture of sorted populations of the EpCAMlo versus the
EpCAMhi LRC subsets revealed that only the EpCAMlo LRC
subset exhibited robust in vitro growth, a property typically
associated with stem cells. Initially these cells maintained
bright H2BGFP expression (Figure 4) confirming that they were
derived from K5-expressing label-retaining epithelial cells,
since the transgene is driven by the K5 promoter and histology
confirmed that the transgene was restricted to K5+ epithelial
cells in the thymus (Figure 1 and 2). Cell surface analysis of
this population following expansion in vitro revealed a cell
surface profile virtually identical to MSCs while the cultured
cells also maintained expression of H2BGFP (confirming their
derivation from label retaining K5-expressing TECs) as well as
both EpCAM and MHCII (Figure 5). Subsequently,
differentiation assays performed with culture expanded LRCs
demonstrated that, like MSCs, they maintained the ability to
differentiate into multiple lineages including osteoblasts,
adipocytes and chondrocytes (Figure 6).
MSCs and tissue specific stem cells show a remarkable
conservation of cell surface markers irrespective of their origin.
Sca1 was shown to be present on hematopoietic, prostate,
lung, cardiac and mammary stem cells, as well as MSCs
isolated from numerous sources [16,44,47,62-65]. α6 integrin/
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CD49F also shows a wide distribution among stem cell types,
especially when it is analyzed with its subunit pair integrin β1/
CD29. Enrichment for skin stem cells was achieved through
sorting CD49FhiCD29hi populations [66,67]. Stingl et al [68]
demonstrated that mammary stem cells express a
Sca1loCD49FhiCD29hi phenotype, while an identical phenotype
was reported for murine prostate stem cells [65]. Microarray
analysis has shown that CD49F is overexpressed consistently
in neural, hematopoietic and embryonic stem cells [69]. Finally
mesenchymal stem cells isolated from a variety of tissues and
organs have also been shown to express Sca1, CD49F and
CD29 as well as CD44 [16,70,71].
Using the cell surface phenotype identified for the H2BGFP
LRCs with in vitro growth potential,
EpCAMloMHCIIloSca1hiCD49loCD29hi, multiple clonal TMSC
lines were created by sorting the same population from up to
eight-month old WT mice. Comparison of the FACS analysis of
the LRCs versus the stroma derived from WT mice (Figure 3)
revealed one significant difference that confirms that label
retention does enrich for a stem cell population in the thymic
stroma. When the EpCAMloMHCIIlo subsets were compared for
Sca1 expression, the WT stroma contains both a Sca1lo and
Sca1hi subset (Figure 3B), while the LRCs contain primarily
Sca1hi cells (Figure 3E & G). When the Sca1 high and low
subsets isolated from WT mice were further analyzed for
expression of CD49F and CD29, only the Sca1hi subset
contains the CD49FloCD29hi subset, which exhibited properties
of mesenchymal stem cells including in vitro growth potential
and significant pluripotency. While not sufficient to completely
identify the stem cell population, label retention enriched for a
population of thymic stroma with stem cells properties, even
when derived from an eight-month old postnatal thymus. This
demonstrates that the postnatal thymus contains a population
of pluripotent stem cells within the
EpCAMloMHCIIloSca1+CD49FloCD29hi subset of thymic stromal
cells. These cells maintain properties of TECs including
EpCAM and FoxN1 that are routinely used to define thymic
epithelium, together with a previously unrecognized
pluripotency more commonly associated with MSCs or other
stem cell populations.
Like the culture-expanded LRCs, TMSC lines maintained a
cell surface phenotype similar to MSCs and the ability to
differentiate into multiple lineages including adipocytes,
osteoblasts and chondrocytes when subjected to differentiation
assays. Gene expression analysis of culture expanded LRCs
revealed a surprisingly diverse gene expression pattern
including a number of core transcription factors typically
associated with pluripotent stem cell populations including
Nanog, Oct4, Sox2, Dppa3 and Lgr5, while at the same time
they expressed genes typically associated with TECs including
EpCAM, MHCII and FoxN1, as well as Notch ligands Dll1, Dll4
and Jagged1. TECs are known to express a diverse set of
peripheral genes, termed tissue restricted gene expression,
driven by the Aire transcription factor [72]. Tissue-restricted
gene expression is needed for deletion of T cells bearing self-
reactive T cell antigen receptors that could ultimately mount
autoimmune responses. Analysis of Aire expression by PCR
and staining with anti-Aire antibodies showed that none of the
TMSC lines expressed Aire, excluding the possibility that the
diverse set of genes expressed by TMSCs represented Aire
dependent tissue restricted antigens. Single cell analysis was
not performed so it is possible that different subsets of cells
existed after prolonged culture that expressed unique
combinations of pluripotent and more mature TEC markers.
However, differentiation assays and cell surface analysis
performed on multiple cell lines at different passages gave
consistent and repeatable results suggesting that the culture
conditions used are maintaining a pluripotent phenotype within
a population of cells that still maintain characteristics that mimic
the epithelial microenvironment from which they were derived.
Epithelial cells are known to arise from all three germ layers,
although thymic epithelium has been shown to arise exclusively
from the third pharyngeal pouch endoderm [73]. Epithelial cells
are typically characterized by the expression of cytokeratins
together with strong intercellular connections and cell polarity.
Mesenchymal cells express vimentin intermediate filaments
and lack distinct intercellular connections [74]. TECs exhibit a
less defined polarity, express a variety of keratins and are
further defined by expression of EpCAM. Typical
undifferentiated MSCs do not express cytokeratins or other
epithelial specific molecules such as occludin or E-cadherin,
however, epithelial cells and mesenchymal cells are known to
share a reciprocal plasticity. Through the processes of
Epithelial Mesenchymal Transition (EMT) and Mesenchymal
Epithelial Transition (MET), cells are thought to shift as needed
between the two phenotypes during normal embryonic
morphogenesis, tumor progression and tissue repair [74].
Indeed, EMT has been described in the thymus and may
contribute to age associated thymic involution and the loss of
functional TECs that are replaced by fibroblasts and eventually
fat in the aging thymus [9-11]. This might explain the unusual
phenotype of the TMSCs described in this study, which appear
to share characteristics of both thymic epithelial cells (K5
driven H2BGFP, Foxn1, EpCAM and MHCII expression) and
MSCs (cell surface phenotype, in vitro growth potential,
morphology and multipotency). Analysis of long-term clonal
TMSC lines showed that MHCII and Foxn1 are completely
absent, while EpCAM expression is highly reduced, suggesting
that culture selects against a TEC phenotype. Interestingly,
mammary epithelial cells that were artificially induced to
undergo EMT took on properties of MSCs including gene
expression and potential for multipotency, much like the
TMSCs that naturally occur in the postnatal thymus [75]. EMT
has also been associated with the acquisition of stem cell like
characteristics in tumor cells, which may be causally linked to
tumor recurrence [70,76,77]. It is intriguing to speculate that
EMT occurring within the thymus as a natural part of thymic
aging may contribute to the development of multipotent stem
cells. Alternatively, the changes in morphology and gene
expression observed might reflect an inherent pluripotency of
TECs coupled with their removal from the thymic
microenvironment and expansion in culture. Recently,
significant pluripotency of TECs was demonstrated when cell
culture expanded TECs derived from fetal and newborn rat
thymus where found to form colonies in culture and could be
reprogrammed into skin multipotent stem cells when
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transplanted into mouse skin in a wound healing assay [78].
Microenvironment clues were sufficient to redirect epithelial
fate allowing the cells, shown to maintain characteristics of
epithelial cells in vitro, to cross primitive germ layer boundaries.
It will be interesting to determine if this is a general property of
thymic stromal components and analyze the potential of the
TMSCs, described in this study, to respond to different in vivo
microenvironments to determine if the postnatal thymus
represents a source of multipotent or truly pluripotent stem
cells.
A number of studies have demonstrated that MSCs isolated
from a variety of sources have the capacity to differentiate into
mesodermal cell types including chondrocytes, osteoblasts,
adipocytes and myocytes when subjected to growth in selective
media with lineage specific inductive factors [16,79-86].
Surprisingly, MSCs also appear to have the capacity to
differentiate into cells of both ectodermal and endodermal
origin. A combination of in vitro and in vivo studies has
documented differentiation of MSCs into neural cells,
hepatocytes, pancreatic islet cells, endothelial cells and
epithelial cells [87-96]. Future efforts will investigate whether
the TMSCs identified in this study contribute to maintenance of
postnatal thymic epithelial microenvironments. While freshly
sorted EpCAMloMHCIIloSca1+CD29+CD49Flo TECS are
maintained in reaggregates and express epithelial
characteristics after three weeks of growth under the nude
mouse kidney capsule (Figure 8), GFP-expressing clonal
TMSC lines are maintained in small numbers but do not
differentiate into TEC under similar conditions (data not
shown). Current efforts are aimed at identifying culture
conditions capable of inducing a TEC progenitor phenotype in
TMSC lines, similar to recent experiments performed with ES
cells that were used to generate functional thymic epithelium
[97].
Due to the avoidance of ethical concerns associated with
embryonic stem cells and the technical challenges and risks
associated with iPS technologies, adult stem cells are the
preferred choice for use in regenerative medicine. This is
particularly true for diseases like osteoporosis and
osteoarthritis where adult tissue derived stem cells might be
used to replace lost bone or cartilage. Thymic tissue is often
removed as a by-product of human heart surgeries, so the
ability to easily derive MSCs from thymic tissue could provide a
potential source of human MSCs. Consistent and reproducible
differentiation of multiple TMSC lines into osteoblasts and
chondrocytes makes the thymus a viable alternative to bone
marrow as a rich source of MSCs.
Supporting Information
Figure S1.  Cell Surface Profile of H2BGFP LRCs. A. Gating
strategy for analysis of LRCs based on EpCAM and H2BGFP
expression during 0-6 week Dox feeding time course. Gate
frequencies from left to right show total H2BGFP+, H2BGFPlo
and H2BGFPhi, respectively. B. Characterization of changes
EpCAM and MHCII expression in total CD45- stroma, total GFP
+, GFPlow and GFPhi subsets, every 2 weeks during a 6-week
Dox time course. C. Characterization of changes in the
frequency of MHCII versus CD80 in total CD45- stroma, total
GFP+, GFPlow and GFPhi subsets, every 2 weeks during a 6-
week Dox time course. D. Characterization of changes EpCAM
and MHCII expression in total CD45- stroma, total GFP+,
GFPlow and GFPhi subsets, every 2 weeks during a 6-week Dox
time course.
(TIF)
Figure S2.  Morphology of TMSC lines in culture. A. Phase
image of TMSC7-10 at P3; B. Phase image of TMSC2-1at P12.
(TIF)
Figure S3.  Gene Expression Profile of clonal TMSC lines.
A. Clonal TMSC lines exhibit a surface profile similar to
mesenchymal stem cells.
Cell surface profile of TMSC7-10 and TMSC2-1 cell lines after
10 passages. For each antibody overlay, the grey filled
histogram shows isotype control antibody staining and the solid
and dotted black histograms shows staining with the specific
antibody for the TMSC7-10 and TMSC2-1 cell lines,
respectively.
B.. Rt-PCR analysis of RNA isolated from TMSC7. Rt-PCR
analysis of RNA isolated at P7 from TMSC7 revealed
expression of core transcription regulators of pluripotent cells
1) Nanog, 2) Oct4 3) Sox2; Genes involved in the maintenance
of pluripotency 4) Foxd3, 5) Lgr5, 6) Dppa3, 7) Utf1;
transcription factors involved in early development of endoderm
8) Fox A1, 9) Cdx1; Key regulators of TEC development 10)
Eya1, 11) Pax9, 12) FoxN1; Proteins typically expressed on
TECs 13) EpCAM, 14) MHCII; Notch ligands expressed on
TECs 15) Dll1, 16) Dll4, 17) Jag1, 18) Jag2; Wnts expressed
by TECs 19) Wnt4, 20) Wnt10b; housekeeping control 21)
HPRT. These results are representative of 5 independent
experiments with 2 distinct TMSC lines performed from
passage 4 to 7.
C. Comparison of Gene expression in sorted TEC subsets and
TMSC7-10 at P16. Total RNA was isolated from TEC subsets
sorted to >95% purity together with the clonal TMSC7-10 cell
line. Quantitative PCR was then performed using a Taqman
assay for the TEC specific markers Foxn1 and EpCAM as well
as the stem cell markers Nanog, Oct4 and Sox2. All results
were normalized to 18SrRNA and compared to the MHCIIint
EpCAMhi TEC subset using the ΔΔCt method.
(TIF)
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